Novartis AG

Healthcare · Drug Manufacturers - General · Switzerland

Last price 160.79 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 306.70B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure; Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6; Promacta/Revolade for immune thrombocytopenia (ITP), thrombocytopenia, and aplastic anemia ...